A Risk-Benefit Assessment of Estrogen Therapy in Postmenopausal Women
- 1 January 1990
- journal article
- review article
- Published by Springer Nature in Drug Safety
- Vol. 5 (5), 345-358
- https://doi.org/10.2165/00002018-199005050-00004
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- The Risk of Breast Cancer after Estrogen and Estrogen–Progestin ReplacementNew England Journal of Medicine, 1989
- Influence of non‐contraceptive exogenous and endogenous sex hormones on breast cancer risk in DenmarkInternational Journal of Cancer, 1988
- A Simple Method for Determining the Optimal Dosage of Progestin in Postmenopausal Women Receiving EstrogensNew England Journal of Medicine, 1986
- Biologic Effects of Transdermal EstradiolNew England Journal of Medicine, 1986
- Postmenopausal Estrogen Use, Cigarette Smoking, and Cardiovascular Morbidity in Women over 50New England Journal of Medicine, 1985
- Effects of Estrogens and Progestins on the Biochemistry and Morphology of the Postmenopausal EndometriumNew England Journal of Medicine, 1981
- Effects of Different Progestogens on Lipoproteins during Postmenopausal Replacement TherapyNew England Journal of Medicine, 1981
- BONE MASS IN POSTMENOPAUSAL WOMEN AFTER WITHDRAWAL OF OESTROGEN/GESTAGEN REPLACEMENT THERAPYThe Lancet, 1981
- Decreased Risk of Fractures of the Hip and Lower Forearm with Postmenopausal Use of EstrogenNew England Journal of Medicine, 1980
- The menopausal syndromeJournal of Epidemiology and Community Health, 1974